Moonwalk Biosciences

We’re excited to announce the launch of Moonwalk Biosciences, a genomic medicine company pioneering precision epigenetic medicines, with $57 million in financing from Alpha Wave Global, ARCH Venture Partners, Future Ventures, GV (Google Ventures), Khosla Ventures and YK Bioventures. By targeting the epigenetic code – the software of the genome – Moonwalk aims to reprogram cells to their healthy state, fundamentally enabling a new approach to how therapies are discovered and developed. Moonwalk is the first company that couples an epigenetic discovery platform with precise engineering – opening up the epigenome as a new target space for complex diseases. Learn more here: https://moonwalk.bio/ Read our press release: https://lnkd.in/gcuF7Umy More info about us in: WSJ: https://lnkd.in/e5_6R2y2 STAT: https://lnkd.in/eViTRJqE Endpoints News: https://lnkd.in/eSySAyWd Biopharma Dive: https://lnkd.in/ei8wKM2n

“We're opening up the epigenome as a platform for drug discovery.” Moonwalk Biosciences is a biotech company devoted to pioneering precision epigenetic medicines. This week on Translating Aging, CEO & co-founder Alex Aravanis MD PhD tells us about Moonwalk’s mission to harness the power of epigenetics to develop a new class of medicines aimed at treating complex diseases and potentially extending human healthspan. Translating Aging is produced by BioAge Labs, a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. Episode: https://lnkd.in/g6XtThZK (click ‘FOLLOW’ for links to your favorite podcast platform) Podcast: https://lnkd.in/gvF4X-ka

Our CBO Elaine Cheung was on a panel at LSX USA Congress in Boston today on Cultivating Success: Establishing an Outstanding Biotech Executive team. The panel was moderated by Leslie Loveless at Slone Partners and also featured Michael Curtis from eGenesis, Inc., Lihua Zheng JD PhD , and Curie.Bio. Fantastic discussion and great to see everyone there! ????

Looking forward to visiting Boston this week, and engaging with colleagues and potential partners!

"Pioneering precision epigenetic medicines." Moonwalk Biosciences is revolutionizing the development of therapies by targeting the epigenome, using advanced AI and engineering tools to reprogram cells for treating complex diseases at their root cause. Learn more:?https://moonwalk.bio #Epigenetics #BiotechInnovation?#SoHCSpotlights

Moonwalk Biosciences Appoints Dr. John Liles as VP Biology and Translational Science; Forms Cardiometabolic Advisory Board Learn more & get our take ?? https://lnkd.in/gdCc5FhH “We are thrilled to welcome John to our team and announce the formation of our cardiometabolic advisory board. John’s expertise in translating innovative therapeutics from discovery through IND will accelerate our ambitious R&D efforts.” — Alex Aravanis MD PhD, Co-founder & CEO at Moonwalk Biosciences “I’m excited to join the Moonwalk team at a pivotal time as the company advances its preclinical efforts to pioneer new insights about epigenetic biology and engineering cell state.” — John Liles, Ph.D., VP Biology and Translational Science at Moonwalk Biosciences #leadership #biology #SoHCNews

We’re excited to welcome John Liles, Ph.D., VP Biology and Translational Science to the Moonwalk team and the formation of a world class Cardiometabolic Advisory Board. Dr. Liles brings deep experience as a drug discovery biologist with proven success advancing novel therapeutics from target discovery through IND for liver, kidney, lung and #cardiovascular diseases. “We are thrilled to welcome John to our team and announce the formation of our cardiometabolic advisory board,” said Alex Aravanis MD PhD, M.D., Ph.D., Co-founder & CEO, Moonwalk Biosciences, “John’s expertise in translating innovative therapeutics from discovery through IND will accelerate our ambitious R&D efforts.” Moonwalk will be presenting data and providing an update at future scientific meetings, including an oral presentation at ObesityWeek? 2024 and a poster presentation at American Association for the Study of Liver Diseases (AASLD) 2024. Read the release: https://lnkd.in/eQK6Uk6G

Great to catch up with Ron Leuty at San Francisco Business Times at #BIO2024: When Moonwalk Biosciences Inc. CEO Alex Aravanis MD PhD started his presentation at the BIO convention in San Diego earlier this week, he saw a standing-room-only crowd, and after his 15-minute talk he was peppered with questions. In more formal meetings with potential partners, Aravanis faced more questions. "I think there's a lot of people who are curious about (epigenetics)" — how DNA modifications can be passed cell to cell —?"curious about the capabilities, how mature it is," Aravanis said. "In the partnering meetings, there're folks who have an immediate use for it, and there are folks who said, 'Look, we reached out to you because we realized this is an exciting new area.'" The ability to spread a company's scientific message with hundreds, if not thousands, of people in a few days is why companies come to the Biotechnology Innovation Organization's annual convention, which closes today in San Diego. More than 20 Bay Area life sciences companies were scheduled among the scores making formal presentations in tiny "theaters" on the convention's exhibit floor, such as South San Francisco's Moonwalk, or in BIO's "Startup Stadium." Read the article (subscription required): https://lnkd.in/eTEdgDEa

Sharing some highlights from our week at #BIO2024. ?????? Our CEO Alex Aravanis MD PhD presenting on #EpiRead and #EpiWrite technology and also discussing the science behind increasing healthspan on a panel discussion. Great meeting everyone this week!

Curious about what we've planned for you at AIDBio 2024? ??? Our stellar lineup of speakers will cover the latest trends and challenges in digital biology, featuring topics like ‘Machine Reasoning for Drug Discovery’ and ‘AI Digital Biology Lab Ecosystem’ Get ready for a morning packed with learning and discovery at the Guggenheim Theater on June 3rd. Don't miss insights from: Pr. Trey Ideker, UCSD Alex Aravanis MD PhD, MD, PhD - CEO Moonwalk Biosciences, Co-Founder of GRAIL, former CTO at Illumina Mike Varney - TNL Advisor, former Head of R&D at Genentech Abraham Heifets - CEO at Atomwise Nick Edwards, PhD - CEO at Potato MyPhuong Le, PhD - President and Cofounder at Aquillius Reza Rassool - Chair at Kwaai Ash Damle - CTO/AI at TNL, MIT Jeff Guise - Partner at Eversheds Sutherland Khai Minh Pham MD, PhD (AI) - CEO and Founder of ThinkingNode Life Check out our full agenda and snag your tickets here: https://lnkd.in/gFVamash John (Bobby) Goulding, Chuck Merryman, Paolo Amedeo, William Dale, PE, Eden Romm, Stefano Ghirlanda, Aline “Ali” Betancourt, Ekaterina (Kate) Migunova, PhD, The Social Coyote